Received 10 August 2016; accepted 1 December 2016 Available online 14 October 2017 A 23-day-old preterm baby (1900 g) presenting with severe hypoxemia secondary to a large pulmonary arteriovenous malformation (PAVM), diagnosed by thoracic computed tomography (CT), was referred to our department.
He was born at 32 weeks of gestation weighing 1945 g and, after birth, presented with severe hypoxemia (peripheral oxygen saturation [SpO 2 ] 65%). The cardiac assessment was unremarkable. The initial diagnosis was congenital pneumonia with persistent pulmonary hypertension of the newborn and he was treated with antibiotics and ventilated with nitric oxide. In the absence of clinical improvement a thoracic CT scan was performed, which raised suspicion of a PAV M (Figure 1) .
Cardiac catheterization performed under general anesthesia demonstrated a large PAV M in the right lower lobe with two afferent arteries, one 3.1 mm and the other 6 mm in diameter. The first was occluded with a 4 mm Amplatzer Figure 2 ). The patient's SpO 2 immediately increased to 98% and he was discharged home 20 days after the procedure. One year later, he remains asymptomatic.
This report emphasizes that percutaneous occlusion of PAV M should be the primary therapeutic option at any age. To our knowledge, this is the first such report in the literature in a low birth weight preterm newborn. Amplatzer ® devices were the appropriate choice as they fit in a small sheath and are repositionable and suitable for large vessels, ensuring a high occlusion rate. 
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